C of A [GxP / QC / QA]

posted by Dr_Dan  – Germany, 2011-02-17 11:26 (5610 d 13:59 ago) – Posting: # 6640
Views: 9,031

Dear VM
usually you perform a clinical study in order to make a statement about the efficacy, the safety, the bioavailability etc. of the tested product. For this you definitely need to know the quality of the product. In your case you just need plasma samples in order to develop a bioanalytical method and there is no gain in knowledge about the drug. That's why I think that a CoA is not of that importance. Nevertheless it is always better to proof the assay content of the drug and if you use the data to describe the pharmacokinetics of the reference product in order to plan a BE study it would be better to have a CoA.
I hope this helps.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
355 visitors (0 registered, 355 guests [including 15 identified bots]).
Forum time: 02:26 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5